Sema4 SPAC

20 Pharma: improving efficiency and outcomes in drug development SEMA4 OFFERING LEAD IDENTIFICATION Clinical trial matching Drive increased probability of success and terminate bad molecules sooner Research DISCOVERY EARLY CLINICAL SaaS-based licensing Reduce trial duration, minimize dose finding / escalation, better patient selectivity Preclinical DEVELOPMENT Phase I Deep JV collaborations leveraging data science PROTOCOL OPTIMIZATION Maximize trial opportunity, reduce time to market, and optimize market access Phase II Phase III REAL WORLD DATA Characterize patient journeys and diagnostic odysseys Phase IV / RWE COMMERCIALIZATION sema4

View entire presentation